These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 34119468)
1. Physical Activity, Subclinical Myocardial Injury, and Risk of Heart Failure Subtypes in Black Adults. Patel KV; Simek S; Ayers C; Neeland IJ; deFilippi C; Seliger SL; Lonergan K; Minniefield N; Mentz RJ; Correa A; Yimer WK; Hall ME; Rodriguez CJ; de Lemos JA; Berry JD; Pandey A JACC Heart Fail; 2021 Jul; 9(7):484-493. PubMed ID: 34119468 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults. Saha A; Patel KV; Ayers C; Ballantyne CM; Correa A; Defilippi C; Hall ME; Mentz RJ; Seliger SL; Yimer W; Butler J; Berry JD; De Lemos JA; Pandey A J Card Fail; 2023 Jan; 29(1):6-15. PubMed ID: 35690315 [TBL] [Abstract][Full Text] [Related]
3. Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults. Zhao L; Zierath R; John JE; Claggett BL; Hall ME; Clark D; Butler KR; Correa A; Shah AM JAMA Netw Open; 2022 Sep; 5(9):e2231878. PubMed ID: 36107422 [TBL] [Abstract][Full Text] [Related]
4. Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study. Pandey A; Keshvani N; Ayers C; Correa A; Drazner MH; Lewis A; Rodriguez CJ; Hall ME; Fox ER; Mentz RJ; deFilippi C; Seliger SL; Ballantyne CM; Neeland IJ; de Lemos JA; Berry JD JAMA Cardiol; 2019 Jan; 4(1):51-58. PubMed ID: 30566191 [TBL] [Abstract][Full Text] [Related]
5. Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction. Myhre PL; O'Meara E; Claggett BL; de Denus S; Jarolim P; Anand IS; Beldhuis IE; Fleg JL; Lewis E; Pitt B; Rouleau JL; Solomon SD; Pfeffer MA; Desai AS Circ Heart Fail; 2018 Nov; 11(11):e005312. PubMed ID: 30571192 [TBL] [Abstract][Full Text] [Related]
6. Accelerometer-Measured Physical Activity, Sedentary Time, and Heart Failure Risk in Women Aged 63 to 99 Years. LaMonte MJ; LaCroix AZ; Nguyen S; Evenson KR; Di C; Stefanick ML; Hyde ET; Anuskiewicz B; Eaton CB JAMA Cardiol; 2024 Apr; 9(4):336-345. PubMed ID: 38381446 [TBL] [Abstract][Full Text] [Related]
7. Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life. Vu K; Claggett BL; John JE; Skali H; Solomon SD; Mosley TH; Williams JE; Kucharska-Newton A; Biering-Sørensen T; Shah AM J Am Heart Assoc; 2021 Dec; 10(23):e020094. PubMed ID: 34796739 [TBL] [Abstract][Full Text] [Related]
8. Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure. Pandey A; LaMonte M; Klein L; Ayers C; Psaty BM; Eaton CB; Allen NB; de Lemos JA; Carnethon M; Greenland P; Berry JD J Am Coll Cardiol; 2017 Mar; 69(9):1129-1142. PubMed ID: 28254175 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction. Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609 [TBL] [Abstract][Full Text] [Related]
10. Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA). Echouffo-Tcheugui JB; Ogunmoroti O; Golden SH; Bertoni AG; Mongraw-Chaffin M; Pandey A; Ndumele CE; Michos ED J Card Fail; 2022 Nov; 28(11):1593-1603. PubMed ID: 35114382 [TBL] [Abstract][Full Text] [Related]
11. Metabolic dysfunction and incidence of heart failure subtypes among Black individuals: The Jackson Heart Study. Kaze AD; Bertoni AG; Fox ER; Hall ME; Mentz RJ; Echouffo-Tcheugui JB Eur J Heart Fail; 2024 Sep; ():. PubMed ID: 39225160 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of High-Sensitivity Troponin I in Risk Stratification and Final Disposition of Patients with Acute Heart Failure in the Emergency Department: Comparison between HFpEF vs. HFrEF. Crisanti L; Valli G; Cennamo E; Capolino A; Fratini P; Cesaro C; Adducchio G; De Magistris A; Terlizzi F; Ruggieri MP; Mirante E; Savoriti C; Sukruang K; Valeriano V; Pugliese FR; Travaglino F; Di Somma S Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676630 [TBL] [Abstract][Full Text] [Related]
13. Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction. Pandey A; Omar W; Ayers C; LaMonte M; Klein L; Allen NB; Kuller LH; Greenland P; Eaton CB; Gottdiener JS; Lloyd-Jones DM; Berry JD Circulation; 2018 Apr; 137(17):1814-1823. PubMed ID: 29352072 [TBL] [Abstract][Full Text] [Related]
14. Exercise training and high-sensitivity cardiac troponin-I in patients with heart failure with reduced ejection fraction. Riveland E; Valborgland T; Ushakova A; Skadberg Ø; Karlsen T; Hole T; Støylen A; Dalen H; Videm V; Koppen E; Linke A; Delagardelle C; Van Craenenbroeck EM; Beckers P; Prescott E; Halle M; Omland T; Ellingsen Ø; Larsen AI; ESC Heart Fail; 2024 Apr; 11(2):1121-1132. PubMed ID: 38268237 [TBL] [Abstract][Full Text] [Related]
15. Exercise training and high-sensitivity cardiac troponin T in patients with heart failure with reduced ejection fraction. Koppen E; Omland T; Larsen AI; Karlsen T; Linke A; Prescott E; Halle M; Dalen H; Delagardelle C; Hole T; van Craenenbroeck EM; Beckers P; Ellingsen Ø; Feiereisen P; Valborgland T; Videm V; ESC Heart Fail; 2021 Jun; 8(3):2183-2192. PubMed ID: 33754453 [TBL] [Abstract][Full Text] [Related]
16. The association of cardiac troponin and cardiovascular events in patients with concomitant heart failure preserved ejection fraction and atrial fibrillation. Kim BS; Kwon CH; Chang H; Choi JH; Kim HJ; Kim SH BMC Cardiovasc Disord; 2023 May; 23(1):273. PubMed ID: 37226163 [TBL] [Abstract][Full Text] [Related]
17. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study). Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111 [TBL] [Abstract][Full Text] [Related]
18. Clonal Hematopoiesis and Incident Heart Failure With Preserved Ejection Fraction. Schuermans A; Honigberg MC; Raffield LM; Yu B; Roberts MB; Kooperberg C; Desai P; Carson AP; Shah AM; Ballantyne CM; Bick AG; Natarajan P; Manson JE; Whitsel EA; Eaton CB; Reiner AP JAMA Netw Open; 2024 Jan; 7(1):e2353244. PubMed ID: 38270950 [TBL] [Abstract][Full Text] [Related]
19. Total brachial artery reactivity and incident heart failure and heart failure subtypes: multi-ethnic study of atherosclerosis. Charry D; Xu J; Tanaka H; Heffernan KS; Richardson MR; Churilla JR Heart Vessels; 2022 Mar; 37(3):411-418. PubMed ID: 34436657 [TBL] [Abstract][Full Text] [Related]
20. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Davis BR; Kostis JB; Simpson LM; Black HR; Cushman WC; Einhorn PT; Farber MA; Ford CE; Levy D; Massie BM; Nawaz S; Circulation; 2008 Nov; 118(22):2259-67. PubMed ID: 19001024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]